BUILDERS FIRSTSOURCE INC (BLDR) Fundamental Analysis & Valuation

NYSE:BLDR • US12008R1077

95.99 USD
-1.46 (-1.5%)
At close: Mar 4, 2026
96.45 USD
+0.46 (+0.48%)
After Hours: 3/4/2026, 8:10:31 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BLDR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

BLDR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Building Products industry. Both the profitability and the financial health of BLDR get a neutral evaluation. Nothing too spectacular is happening here. BLDR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. BLDR Profitability Analysis

1.1 Basic Checks

  • In the past year BLDR was profitable.
  • BLDR had a positive operating cash flow in the past year.
  • BLDR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BLDR had a positive operating cash flow.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • BLDR has a Return On Assets (3.87%) which is in line with its industry peers.
  • BLDR has a Return On Equity (10.00%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 6.62%, BLDR is doing worse than 61.90% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLDR is above the industry average of 11.86%.
  • The last Return On Invested Capital (6.62%) for BLDR is well below the 3 year average (13.95%), which needs to be investigated, but indicates that BLDR had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.87%
ROE 10%
ROIC 6.62%
ROA(3y)9.58%
ROA(5y)14.16%
ROE(3y)22.55%
ROE(5y)31.79%
ROIC(3y)13.95%
ROIC(5y)19.93%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • With a Profit Margin value of 2.86%, BLDR perfoms like the industry average, outperforming 40.48% of the companies in the same industry.
  • BLDR's Profit Margin has declined in the last couple of years.
  • The Operating Margin of BLDR (5.18%) is worse than 76.19% of its industry peers.
  • In the last couple of years the Operating Margin of BLDR has declined.
  • Looking at the Gross Margin, with a value of 30.39%, BLDR is in line with its industry, outperforming 52.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BLDR has grown nicely.
Industry RankSector Rank
OM 5.18%
PM (TTM) 2.86%
GM 30.39%
OM growth 3Y-32.17%
OM growth 5Y-4.02%
PM growth 3Y-38.13%
PM growth 5Y-4.83%
GM growth 3Y-3.75%
GM growth 5Y3.19%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BLDR Health Analysis

2.1 Basic Checks

  • BLDR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, BLDR has less shares outstanding
  • Compared to 5 years ago, BLDR has less shares outstanding
  • BLDR has a worse debt/assets ratio than last year.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.67 indicates that BLDR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of BLDR (2.67) is comparable to the rest of the industry.
  • The Debt to FCF ratio of BLDR is 5.21, which is a neutral value as it means it would take BLDR, 5.21 years of fcf income to pay off all of its debts.
  • BLDR has a Debt to FCF ratio (5.21) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.02 is on the high side and indicates that BLDR has dependencies on debt financing.
  • BLDR has a worse Debt to Equity ratio (1.02) than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 5.21
Altman-Z 2.67
ROIC/WACC0.73
WACC9.07%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • BLDR has a Current Ratio of 1.86. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.86, BLDR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • A Quick Ratio of 1.16 indicates that BLDR should not have too much problems paying its short term obligations.
  • BLDR has a Quick ratio (1.16) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.16
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BLDR Growth Analysis

3.1 Past

  • BLDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.24%.
  • Measured over the past years, BLDR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.40% on average per year.
  • The Revenue has decreased by -7.38% in the past year.
  • The Revenue has been growing by 12.16% on average over the past years. This is quite good.
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y-12.57%
Revenue growth 5Y12.16%
Sales Q2Q%2.37%

3.2 Future

  • Based on estimates for the next years, BLDR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.16% on average per year.
  • Based on estimates for the next years, BLDR will show a small growth in Revenue. The Revenue will grow by 4.01% on average per year.
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. BLDR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.93, the valuation of BLDR can be described as correct.
  • Based on the Price/Earnings ratio, BLDR is valued a bit cheaper than 78.57% of the companies in the same industry.
  • BLDR is valuated rather cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • BLDR is valuated correctly with a Price/Forward Earnings ratio of 15.70.
  • 71.43% of the companies in the same industry are more expensive than BLDR, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of BLDR to the average of the S&P500 Index (25.11), we can say BLDR is valued slightly cheaper.
Industry RankSector Rank
PE 13.93
Fwd PE 15.7
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLDR is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLDR indicates a rather cheap valuation: BLDR is cheaper than 80.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.44
EV/EBITDA 10.79
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • BLDR's earnings are expected to grow with 14.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.8
EPS Next 2Y7.34%
EPS Next 3Y14.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLDR Dividend Analysis

5.1 Amount

  • BLDR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLDR Fundamentals: All Metrics, Ratios and Statistics

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (3/4/2026, 8:10:31 PM)

After market: 96.45 +0.46 (+0.48%)

95.99

-1.46 (-1.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-17
Earnings (Next)04-29
Inst Owners104.69%
Inst Owner Change-5.29%
Ins Owners2.49%
Ins Owner Change0.08%
Market Cap10.61B
Revenue(TTM)15.19B
Net Income(TTM)435.20M
Analysts71.33
Price Target131.26 (36.74%)
Short Float %4.37%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.45%
Min EPS beat(2)-11.6%
Max EPS beat(2)12.49%
EPS beat(4)3
Avg EPS beat(4)3.94%
Min EPS beat(4)-11.6%
Max EPS beat(4)12.49%
EPS beat(8)7
Avg EPS beat(8)6.47%
EPS beat(12)11
Avg EPS beat(12)20.34%
EPS beat(16)15
Avg EPS beat(16)32.8%
Revenue beat(2)1
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-4.82%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-2.35%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-4.56%
Revenue beat(12)4
Avg Revenue beat(12)-2.6%
Revenue beat(16)8
Avg Revenue beat(16)1.22%
PT rev (1m)-2.06%
PT rev (3m)-4.93%
EPS NQ rev (1m)-50.46%
EPS NQ rev (3m)-54.66%
EPS NY rev (1m)-2.99%
EPS NY rev (3m)-7.88%
Revenue NQ rev (1m)-4.69%
Revenue NQ rev (3m)-6.02%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 13.93
Fwd PE 15.7
P/S 0.7
P/FCF 12.44
P/OCF 8.73
P/B 2.44
P/tB N/A
EV/EBITDA 10.79
EPS(TTM)6.89
EY7.18%
EPS(NY)6.11
Fwd EY6.37%
FCF(TTM)7.72
FCFY8.04%
OCF(TTM)11
OCFY11.45%
SpS137.37
BVpS39.36
TBVpS-8.76
PEG (NY)N/A
PEG (5Y)0.8
Graham Number78.11
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 10%
ROCE 8.14%
ROIC 6.62%
ROICexc 6.75%
ROICexgc 15.37%
OM 5.18%
PM (TTM) 2.86%
GM 30.39%
FCFM 5.62%
ROA(3y)9.58%
ROA(5y)14.16%
ROE(3y)22.55%
ROE(5y)31.79%
ROIC(3y)13.95%
ROIC(5y)19.93%
ROICexc(3y)14.13%
ROICexc(5y)20.13%
ROICexgc(3y)32.17%
ROICexgc(5y)46.7%
ROCE(3y)17.15%
ROCE(5y)24.51%
ROICexgc growth 3Y-43.15%
ROICexgc growth 5Y-9.26%
ROICexc growth 3Y-42.43%
ROICexc growth 5Y-16.42%
OM growth 3Y-32.17%
OM growth 5Y-4.02%
PM growth 3Y-38.13%
PM growth 5Y-4.83%
GM growth 3Y-3.75%
GM growth 5Y3.19%
F-Score5
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 5.21
Debt/EBITDA 3.21
Cap/Depr 61.31%
Cap/Sales 2.39%
Interest Coverage 3.02
Cash Conversion 88.24%
Profit Quality 196.07%
Current Ratio 1.86
Quick Ratio 1.16
Altman-Z 2.67
F-Score5
WACC9.07%
ROIC/WACC0.73
Cap/Depr(3y)71.45%
Cap/Depr(5y)64.89%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.03%
Profit Quality(3y)151.11%
Profit Quality(5y)131.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y-12.57%
Revenue growth 5Y12.16%
Sales Q2Q%2.37%
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A
EBIT growth 1Y-50.7%
EBIT growth 3Y-40.7%
EBIT growth 5Y7.65%
EBIT Next Year35.74%
EBIT Next 3Y19.17%
EBIT Next 5YN/A
FCF growth 1Y-42.81%
FCF growth 3Y-36.03%
FCF growth 5Y41.96%
OCF growth 1Y-35.07%
OCF growth 3Y-30.35%
OCF growth 5Y36.13%

BUILDERS FIRSTSOURCE INC / BLDR FAQ

Can you provide the ChartMill fundamental rating for BUILDERS FIRSTSOURCE INC?

ChartMill assigns a fundamental rating of 4 / 10 to BLDR.


What is the valuation status of BUILDERS FIRSTSOURCE INC (BLDR) stock?

ChartMill assigns a valuation rating of 5 / 10 to BUILDERS FIRSTSOURCE INC (BLDR). This can be considered as Fairly Valued.


Can you provide the profitability details for BUILDERS FIRSTSOURCE INC?

BUILDERS FIRSTSOURCE INC (BLDR) has a profitability rating of 5 / 10.


Can you provide the financial health for BLDR stock?

The financial health rating of BUILDERS FIRSTSOURCE INC (BLDR) is 4 / 10.


What is the earnings growth outlook for BUILDERS FIRSTSOURCE INC?

The Earnings per Share (EPS) of BUILDERS FIRSTSOURCE INC (BLDR) is expected to decline by -11.26% in the next year.